Patients' and clinicians' attitudes after the Women's Health Initiative study
Author
dc.contributor.author
Blümel, Juan Enrique
Author
dc.contributor.author
Castelo-Branco, Camil
Author
dc.contributor.author
Chedraui, Peter A.
Author
dc.contributor.author
Binfa Esbir, Lorena
Author
dc.contributor.author
Dowlani, Bravna
Author
dc.contributor.author
Gómez, María Soledad
Author
dc.contributor.author
Sarrá, Salvador
Admission date
dc.date.accessioned
2019-01-29T17:57:17Z
Available date
dc.date.available
2019-01-29T17:57:17Z
Publication date
dc.date.issued
2004
Cita de ítem
dc.identifier.citation
Menopause, Volumen 11, Issue 1, 2018, Pages 57-61
Identifier
dc.identifier.issn
10723714
Identifier
dc.identifier.other
10.1097/01.GME.0000075503.60230.61
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/163983
Abstract
dc.description.abstract
Objective: To assess the effect of the publication of the Women's Health Initiative (WHI) study on patients' and physicians' attitudes in relation to hormone therapy (HT). Design: A survey focused on the degree of knowledge and on the reactions to the WHI study was administered to 600 women allocated in two groups according to their socioeconomic status, high (HSES) or low (LSES). Additionally, 283 physicians were surveyed to determine their attitudes regarding HT after the publication of the WHI study. The rates of HT prescription before and after publication of the study were compared. Results: Among patients, HT use and knowledge of the WHI study were less common among women of lower socioeconomic status (LSES 16.7% v HSES 47.3%, and LSES 15.7% v HSES 67.3%; P < 0.0001). Of the women in the LSES group who were HT users and had knowledge on the subject of the WHI study (n = 30), 56.7% contacted their physicians and 6.6% abandoned HT. These rates were similar for women in the HSES gro